Sprouty1 induces a senescence-associated secretory phenotype by regulating NFκB activity: implications for tumorigenesis

被引:0
作者
A Macià
M Vaquero
M Gou-Fàbregas
E Castelblanco
J M Valdivielso
C Anerillas
D Mauricio
X Matias-Guiu
J Ribera
M Encinas
机构
[1] Universitat de Lleida/Institut de Recerca Biomèdica de Lleida,Department of Experimental Medicine
[2] Edifici Biomedicina I,Department of Endocrinology
[3] Lab 2.8,Department of Experimental Nephrology
[4] Universitat de Lleida/Institut de Recerca Biomèdica de Lleida,Department of Pathology
[5] Universitat de Lleida/Institut de Recerca Biomèdica de Lleida,undefined
[6] Universitat de Lleida/Institut de Recerca Biomèdica de Lleida,undefined
[7] Present Address: Department of Endocrinology,undefined
[8] University Hospital Germans Trias Pujol,undefined
[9] 08916 Badalona,undefined
[10] Spain.,undefined
来源
Cell Death & Differentiation | 2014年 / 21卷
关键词
cellular senescence; tumor suppressors; sprouty; Pten; SASP; IL-6;
D O I
暂无
中图分类号
学科分类号
摘要
Genes of the Sprouty family (Spry1–4) are feedback inhibitors of receptor tyrosine kinase (RTK) signaling. As such, they restrain proliferation of many cell types and have been proposed as tumor-suppressor genes. Although their most widely accepted target is the Extracellular-regulated kinases (ERK) pathway, the mechanisms by which Spry proteins inhibit RTK signaling are poorly understood. In the present work, we describe a novel mechanism by which Spry1 restricts proliferation, independently of the ERK pathway. In vivo analysis of thyroid glands from Spry1 knockout mice reveals that Spry1 induces a senescence-associated secretory phenotype via activation of the NFκB pathway. Consistently, thyroids from Spry1 knockout mice are bigger and exhibit decreased markers of senescence including Ki67 labeling and senescence-associated β-galactosidase. Although such ‘escape’ from senescence is not sufficient to promote thyroid tumorigenesis in adult mice up to 5 months, the onset of Phosphatase and tensin homolog (Pten)-induced tumor formation is accelerated when Spry1 is concomitantly eliminated. Accordingly, we observe a reduction of SPRY1 levels in human thyroid malignancies when compared with non-tumoral tissue. We propose that Spry1 acts as a sensor of mitogenic activity that not only attenuates RTK signaling but also induces a cellular senescence response to avoid uncontrolled proliferation.
引用
收藏
页码:333 / 343
页数:10
相关论文
共 300 条
[1]  
Guy GR(2009)Sprouty proteins: modified modulators, matchmakers or missing links? J Endocrinol 203 191-202
[2]  
Jackson RA(2009)Intermolecular interactions of Sprouty proteins and their implications in development and disease Mol Pharmacol 76 679-691
[3]  
Yusoff P(2005)Epigenetic inactivation of the human sprouty2 (hSPRY2) homologue in prostate cancer Oncogene 24 2166-2174
[4]  
Chow SY(2006)Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinoma Endocr Relat Cancer 13 839-849
[5]  
Edwin F(2009)Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas Blood 113 2478-2487
[6]  
Anderson K(2006)Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma Cancer Res 66 2048-2058
[7]  
Ying C(2010)Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma Hum Pathol 42 185-193
[8]  
Patel TB(2012)Sprouty1 is a candidate tumor-suppressor gene in medullary thyroid carcinoma Oncogene 31 3961-3972
[9]  
McKie AB(1991)Detection of interleukin-6 and interleukin-1 production in human thyroid epithelial cells by non-radioactive Clin Exp Immunol 83 314-319
[10]  
Douglas DA(1992) hybridization and immunohistochemical methods Lancet 340 633-636